BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9024520)

  • 1. Successful management with interferon alpha-2a after prednisone therapy failure in an infant with a giant cavernous hemangioma.
    Castello MA; Ragni G; Antimi A; Todini A; Patti G; Lubrano R; Clerico A; Calisti A
    Med Pediatr Oncol; 1997 Mar; 28(3):213-5. PubMed ID: 9024520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon alpha-2a therapy of consumptive coagulopathy in Kasabach-Merritt syndrome.
    Klein C; Hauser M; Hadorn HB
    Eur J Pediatr; 1992 Dec; 151(12):919. PubMed ID: 1473549
    [No Abstract]   [Full Text] [Related]  

  • 3. [The interferon alfa-2a treatment of the severe form of the Kasabach-Merritt syndrome with neonatal onset].
    González de Dios J; Moya Benavent M; Herranz Sánchez Y; Juste Ruiz M; González Montero R
    An Esp Pediatr; 1996 Feb; 44(2):179-83. PubMed ID: 8830584
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diagnostic image (322). A neonate with a swelling on one leg. Kasabach Merritt syndrome].
    Schoot RA; Buter NH
    Ned Tijdschr Geneeskd; 2007 May; 151(18):1013. PubMed ID: 17508685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy.
    Ezekowitz RA; Mulliken JB; Folkman J
    N Engl J Med; 1992 May; 326(22):1456-63. PubMed ID: 1489383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Giant cavernous haemangioma with Kasabach-Merritt syndrome: a case report and review.
    Frevel T; Rabe H; Uckert F; Harms E
    Eur J Pediatr; 2002 May; 161(5):243-6. PubMed ID: 12012216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kasabach-Merritt syndrome in infants.
    Esterly NB
    J Am Acad Dermatol; 1983 Apr; 8(4):504-13. PubMed ID: 6853783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful management of an infant with a giant hemangioma of the retroperitoneum and Kasabach-Merritt syndrome with alpha-interferon.
    Hatley RM; Sabio H; Howell CG; Flickinger F; Parrish RA
    J Pediatr Surg; 1993 Oct; 28(10):1356-7; discussion 1358-9. PubMed ID: 8263701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Submandibular hemangioma as the initial manifestation of Kasabach-Merritt syndrome.
    Seo W; Kishimoto M; Minato T; Nishimura Y
    Int J Pediatr Otorhinolaryngol; 1993 Jan; 25(1-3):269-76. PubMed ID: 8436476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brachial plexus paralysis due to giant cavernous hemangioma with Kasabach-Merritt syndrome: successful management with interferon alpha.
    Peker E; Kirimi E; Tuncer O; Ceylan A; Oner AF
    Platelets; 2009 Dec; 20(8):603-5. PubMed ID: 19929246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tranexamic acid in the treatment of Kasabach-Merritt syndrome in infants.
    Hanna BD; Bernstein M
    Am J Pediatr Hematol Oncol; 1989; 11(2):191-5. PubMed ID: 2751074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cavernous hemangioma and disseminated intravascular coagulation (Kasabach-Merritt syndrome) in a newborn infant with a large ventricular septal defect].
    Paul T; Trowitzsch E; Barthels M; Kallfelz HC
    Monatsschr Kinderheilkd; 1986 Nov; 134(11):815-8. PubMed ID: 3807921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness and dangers of interferon-alpha in the treatment of severe hemangiomas in infants].
    Grimal I; Duveau E; Enjolras O; Verret JL; Giniès JL
    Arch Pediatr; 2000 Feb; 7(2):163-7. PubMed ID: 10701062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful interferon therapy in a neonate with life-threatening Kasabach-Merritt syndrome.
    Nako Y; Fukushima N; Igarashi T; Hoshino M; Sugiyama M; Tomomasa T; Morikawa A
    J Perinatol; 1997; 17(3):244-7. PubMed ID: 9210084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cavernous hemangiomas associated with scoliosis and a localized consumptive coagulopathy. A case report.
    Lozman J; Holmblad J
    J Bone Joint Surg Am; 1976 Oct; 58(7):1021-4. PubMed ID: 977612
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of childhood angiomatous diseases with recombinant interferon alfa-2a.
    White CW; Wolf SJ; Korones DN; Sondheimer HM; Tosi MF; Yu A
    J Pediatr; 1991 Jan; 118(1):59-66. PubMed ID: 1986099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cavernous haemangioma with Kasabach-Merritt syndrome: treatment with alpha-interferon.
    Ettlinger JJ; Fleming PJ; Joffe HS; Kennedy CT
    J R Soc Med; 1996 Jan; 89(1):55P-6P. PubMed ID: 8709089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spindle cell (Kaposiform) hemangioendothelioma with Kasabach-Merritt syndrome in an infant: successful treatment with alpha-2A interferon.
    Deb G; Jenkner A; De Sio L; Boldrini R; Bosman C; Standoli N; Donfrancesco A
    Med Pediatr Oncol; 1997 May; 28(5):358-61. PubMed ID: 9121401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon alpha-2a therapy for disseminated intravascular coagulation in a patient with blue rubber bleb nevus syndrome. A case report.
    Kunishige M; Azuma H; Masuda K; Shigekiyo T; Arii Y; Kawai H; Saito S
    Angiology; 1997 Mar; 48(3):273-7. PubMed ID: 9071205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant alpha-interferon treatment of intracranial hemangioma and Kasabach-Merritt syndrome in an infant with cytomegalovirus.
    Chiu HH; Chen RL; Lin KH; Lin DT; Lin KS
    J Formos Med Assoc; 1995 May; 94(5):261-6. PubMed ID: 7613260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.